tiprankstipranks
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
US Market
PCVX
Vaxcyte
RESEARCH TOOLSreports
Want to see PCVX full AI Analyst Report?

Vaxcyte (PCVX) Stock News & Sentiment

474 Followers
Vaxcyte Appoints New Chief Medical Officer, Updates Trial Timeline
Premium
Company Announcements
Vaxcyte Appoints New Chief Medical Officer, Updates Trial Timeline
7d ago
8K
PCVX
Analyst Reiterates Buy Rating and Maintains $110 Price Target on Robust Vaccine Pipeline and Upcoming Clinical Catalysts
Premium
Ratings
Analyst Reiterates Buy Rating and Maintains $110 Price Target on Robust Vaccine Pipeline and Upcoming Clinical Catalysts
1M ago
PCVX
Vaxcyte Announces Board Transition and New Director Appointment
Premium
Company Announcements
Vaxcyte Announces Board Transition and New Director Appointment
3M ago
8K
PCVX
Vaxcyte Shareholders Reelect Directors, Approve Governance Measures
Premium
Company Announcements
Vaxcyte Shareholders Reelect Directors, Approve Governance Measures
3M ago
8K
PCVX
Vaxcyte’s New VAX-A1 Trial: Early Move Into Group A Strep Vaccines
Premium
Company Announcements
Vaxcyte’s New VAX-A1 Trial: Early Move Into Group A Strep Vaccines
3M ago
PCVX
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate
Premium
Company Announcements
Vaxcyte Earnings Call: Cash Strength, Trials Accelerate
6M ago
PCVX
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans
Premium
Company Announcements
Regulatory Timing Risks: How FDA Delays Could Derail Vaxcyte’s Development and Commercialization Plans
7M ago
PCVX
More PCVX News >

PCVX News on the Web

Deep Track Capital, LP Acquires Jatt III Acquisition Corp (JTTT) Shares on IPO Day
GuruFocus News
Neutral
RA Capital Management Initiates Position in Jatt III Acquisition Corp (JTTT) With 450,000-Share ...
GuruFocus News
Neutral
Vaxcyte (PCVX) Sets Phase 3 Pneumococcal Vaccine Data Release, Market Pricing Reflects Growth ...
GuruFocus News
Neutral
The Next Year Will Define Vaxcyte’s (PCVX) Vaccine Gamble
Insider Monkey
Neutral
Vaxcyte Appoints Luis Jodar, David McAvoy To Leadership Team; Accelerates Phase 3 VAX-31 Timeline
rttnews
Bullish
Seth Klarman’s hedge fund Baupost buys Into Ackman’s Pershing Square, adds to tech bets
CNBC
Neutral
Vaxcyte Slides As Traders Cash In On Vaccine Hype
TipRanks News
Neutral
Paradigm Biocapital Advisors LP Acquires Significant Stake in MBX Biosciences Inc
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
PCVX
Sector Average
Media Buzz
This Week6 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PCVX’s Media Buzz Sentiment?
6 articles about PCVX were published this week. In an average week, 1.5 articles are published.
    What is PCVX’s weekly average amount of articles?
    In an average week, 1.5 articles about PCVX are published.
      What is PCVX’s News Sentiment?
      50% of articles about PCVX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        NTLAIntellia Therapeutics
        BAYRYBayer
        GHGuardant Health
        ROIVRoivant Sciences
        CMPSCOMPASS Pathways
        Showing the stocks with the most bullish news sentiment over the past week